Replies to post #10923 on Intellect Neurosciences Inc. (fka ILNS)

[derrickcan]

This company has hundreds of millions of dollars in future milestone payments and the stock is valued at the equivalent of one milestone payment. Maza is walking a very thin line right now and you can be assured that some investigator is going to snoop into what he does on Fridays (if that is the day Maza works for ILNS).

I feel that we are about to get a fair value deal for the assets.

I feel sympathy for the emotional attachment that you seem to have for the company and Chain, but I don't see a future for this company as a going concern, best is to liquidate.

Has anyone ever put a value on the patent assets? If so, what is the balance after any debt payable?

[itwillgetbetter]

Depends on what you consider fully.I say any company even one as big as Pfizer that has preferred shares whatever class when it reports no way is it fully.

My point insiders stay in control of a small company holding preferred shares with little downside risk or alot less then common and can almost do whatever they want at anytime.

IMHO Chain owns more then 50.1% of ILNS in preferred shares and he has never ever sold a single share and thats a fact.See part of a email he sent 2/09/13.

By the way, I have never sold a single share in Intellect.




Daniel